Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

NCT01434381 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: Pfs25-EPA/Alhydrogel

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)